Introduction
============

The current standard of care for patients with cervical spondylotic radiculopathy or myelopathy involving ≤3-levels is anterior cervical discectomy and fusion (ACDF) \[[@B1][@B2]\]. Since its inception over 60 year ago, a multitude of studies have demonstrated the effectiveness of ACDF \[[@B1][@B3]\]. Although it was shown to have successful outcomes, ACDF relies on the formation of a solid fusion. Results from a meta-analysis based on level 1 data from six Food and Drug Administration (FDA) investigational device exemption (IDE) studies show that ACDF has a 9.8% of reoperation rate and 68% of clinical success rate \[[@B4]\].

Adjacent segment pathology is one important factor that can have negative long-term effects on the clinical results of cervical fusion. In a recent systematic review assessing the risks of adjacent segment pathology, Lawrence et al. \[[@B5]\] found the prevalence of adjacent segment pathology to range from 11%-12% at 5 years, 16%-38% at 10 years, and 33% at 17 years. They also showed that the mean rate of development for symptomatic degeneration in the cervical spine after arthrodesis is estimated between 1.6%-4.2% per year, and the mean rate of reoperation for clinical adjacent level pathology is estimated at 0.8% per year.

Recently, cervical arthroplasty has emerged as an alternative surgical option to cervical arthrodesis. The theoretical benefits of cervical arthroplasty on adjacent level pathology rely on its motion sparing properties. A number of biomechanical studies suggest that cervical arthroplasty mimics natural cervical motion at the operated level while ACDF does not \[[@B6][@B7][@B8]\]. According to the current standards of care for cervical disc replacement (CDR), it has been estimated that cervical arthroplasty procedures would be performed in 43% of the patients who require surgery for degenerative pathology of the cervical spine \[[@B9]\]. With increasing number of patients and longer follow-up periods, complications related to the device and/or aging spine may grow, leaving us with a new challenge in the management and surgical intervention of cervical artificial discs. The lack of literature and no guidelines in the management of failed CDRs makes this an important topic for discussion.

Indications for and Contraindications to CDR
============================================

The main goals of CDR are to avoid fusion of the affected segments, maintain mobility of the involved levels, allow for a speedy return to activity, and eliminate adjacent-segment disease \[[@B10]\]. Indications for CDR include radiculopathy caused by disc herniation, radiculopathy caused by foraminal osteophytes, myelopathy due to a soft disc herniation, and failure of conservative management of single-level disc or spondylosis meeting the appropriate criteria ([Table 1](#T1){ref-type="table"}) \[[@B9][@B11]\]. Contraindications to cervical total disc replacement (TDR) are summarized in [Table 2](#T2){ref-type="table"} \[[@B9]\].

Approved CDR Devices
====================

To date, six CDR devices have been approved by the United States FDA for one-level, and one device has been approved for two-level anterior cervical disc procedures from C3 to C7. The three devices initially approved by the FDA include the Bryan Cervical Disc (Medtronic Sofamor Danek, Memphis, TN, USA; approved on May 12, 2009) \[[@B12]\], the Prestige Cervical Disc (Medtronic Sofamor Danek, Memphis, TN, USA; approved on July 16, 2007) \[[@B13]\], and the ProDisc-C (Synthes Spine, West Chester, PA, USA; approved on December 17, 2007) \[[@B14]\]. Since late 2012, three more devices have been approved by FDA which include the Mobi-C Cervical Disc Prosthesis (LDR Spine, Austin, TX, USA; approved on August 7, 2013) \[[@B15]\], the PCM Cervical Disc (NuVasive, San Diego, CA, USA; approved on October 26, 2012) \[[@B16]\], and the Secure-C Disc (Globus Medical, Audubon, PA, USA; approved on September 28, 2012) \[[@B17]\]. Of these six devices, the Bryan cervical disc has the longest reported radiological and clinical follow-ups \[[@B10]\]. On August 23, 2013, Mobi-C Cervical Disc Prosthesis (LDR Spine, Austin, TX) was approved for two-level CDR in adjacent discs from C3 to C7 \[[@B18]\].

Current Experiences with CDR
============================

In the initial European prospective, multi-centered trial of the Bryan disc evaluating patient\'s pain, neurological function and range of motion at the implanted level at 6 months and 1 year after implantation showed clinical success rate of 86% and 90%, respectively \[[@B19]\]. Initial studies comparing the outcomes of cervical arthroplasty versus arthrodesis did not show much difference between the two groups \[[@B20][@B21][@B22]\]. A prospective, multi-centered, randomized control trial for the treatment of persistent radiculopathy or myelopathy, due to single-level cervical disc herniation or spondylosis, showed that at forty-eight months follow up, the Bryan cervical disc group had significantly superior outcomes in neck disability index (*p*\<0.001), neck pain score (*p*=0.001), arm pain score (*p*=0.028), and Short Form-36 physical component score (*p*=0.007) compared with cervical arthrodesis \[[@B23]\]. The latest prospective, multi-centered, randomized, and controlled IDE study evaluating the clinical safety and effectiveness of the Secure-C Disc demonstrated clinically significant improvement in pain and function in terms of neck disability index, visual analog scale, and 36-Item Short Form Health Survey \[[@B24]\].

Although CDR appears to be an acceptable alternative to ACDF, there is currently no strong evidence to support the routine use of CDR over ACDF in single-level cervical spondylosis surgery \[[@B25][@B26]\].

Adjacent Segment Disease
========================

To date, studies assessing the incidence of adjacent segment disease, by comparing arthrodesis to arthroplasty, have failed to show any statistically significant reduction in the incidence of adjacent level degeneration between the two groups \[[@B27][@B28]\]. Nunley et al. \[[@B28]\] examined the outcomes at 4 and 7 years for the patients enrolled in five different cervical arthroplasty trials and found a 2.3% of incidence rate in symptomatic adjacent segment disease. In another study, after a mean follow up of 41.5 months, no difference was found in the rate of additional surgery for symptomatic adjacent segment disease in patients who underwent fusion compared to disc replacement \[[@B29]\]. Sasso et al. \[[@B30]\] compared the outcomes in 242 patients undergoing cervical arthroplasty versus 221 ACDF and found a 4.1% rate of secondary surgical procedures at adjacent levels, which was same in both groups. A prospective randomized trial by Nunley et al. \[[@B31]\], which assessed the factors affecting the incidence of symptomatic adjacent level disease, found that the risk of developing adjacent segment degeneration was equivalent at median of 38 months after both ACDF and CDR.

Complications
=============

Surgical approach-related complications were similar between ACDF and CDR. Perioperative complications included wound hematoma, epidural hematoma, superficial or deep wound infection, dysphagia, esophageal or laryngeal injury, thoracic duct injury, angioedema, respiratory insufficiency, vertebral artery, carotid artery or jugular vein laceration, pseudoaneurysm formation, recurrent laryngeal nerve palsy, Horner\'s syndrome, dural laceration, and cerebrospinal fluid leak ([Table 3](#T3){ref-type="table"}) \[[@B32]\].

Failures
========

Failure of cervical disc arthroplasty was due to a number of factors. Poor patient selection, inadequate preoperative planning, suboptimal surgical technique, and malpositioning of the device accounted for the majority of the implant failures, with mechanical implant failure and biologic and chemical failure defining the remainder ([Fig. 1](#F1){ref-type="fig"}). Although many of the complications that were experienced in cervical arthroplasty were also seen in cervical arthrodesis procedures ([Table 3](#T3){ref-type="table"}) \[[@B32]\], there were specific complications related to CDR ([Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}) \[[@B22][@B27][@B32][@B33][@B34][@B35][@B36][@B37][@B38][@B39][@B40][@B41][@B42][@B43][@B44][@B45][@B46][@B47][@B48][@B49][@B50][@B51][@B52][@B53]\].

Rates of Reoperation, Revision and Removal
==========================================

Surgical interventions following CDR and ACDF can be divided into reoperations, revisions, and removals. The FDA defines a reoperation as any procedure at the target level that does not remove, modify, or add any original implant component \[[@B54]\]. In the case of CDR and ACDF, reoperation includes laminoforaminotomy, laminectomy, and/or posterior fusion. The FDA defines revision surgery as a procedure that adjusts or modifies, in any way, the original implant configuration \[[@B54]\]. The FDA defines removal surgery as a procedure that removes one or more components of the original implant replacing it with a different type of implant \[[@B54]\]. An additional surgical intervention in ACDF is supplemental fixation, which is performed in the cases of pseudarthrosis.

1. CDR
------

Surgical intervention rates following CDR have been reported in the FDA IDE studies as well as in several larger series published in the literature. From a total of 1,068 cervical arthroplasty levels operated with a mean follow-up of 2.3 years (range, 2-4 years), we established the mean rate of reoperation at 1.0% (range, 0%-3.1%), revision at 0.2 % (range, 0%-0.5%), and removal at 1.2% (range, 0%-1.9%) ([Table 5](#T5){ref-type="table"}) \[[@B22][@B23][@B30][@B35][@B36][@B38][@B44][@B55]\].

2. ACDF
-------

Studies comparing CDR versus ACDF were used to calculate the surgical intervention rates following ACDF. From a total of 744 ACDF levels operated with a mean follow-up of 3.2 years (range, 2-4 years), we established the mean rate of reoperation at 1.7% (range, 0%-3.4%), revision at 1.5% (range, 0%-4.7%), removal at 2.0% (range, 0%-3.4%), and supplemental fixation at 2.4% (range, 0%-3.4%) \[[@B23][@B30][@B35][@B36][@B55][@B56]\].

Discussion
==========

1. Options for failed CDR
-------------------------

The options for surgical intervention depend on the nature of the complication and on radiographic and clinical picture of the patient. In the cases of infection with extrusion, gross malposition, subsidence, or retropulsion, the most suitable option is explantation of the device followed by fusion. Similar to most implants, explantation can result in the removal of excessive bone in one or both vertebral bodies. In those circumstances, the amount of bone removed will dictate the need for a single or double level corpectomy; and in extreme cases where an anterior plate cannot fit, a cage followed by a posterior instrumented fusion is necessary. In patients who are symptomatic from malalignment or subsidence but lack neurologic symptoms, a posterior instrumented fusion alone is a viable option. Yet, another theoretical option, in the cases of frank device malfunction and even malalignment, is the removal of the device followed by reimplantation with a new implant. In patients with radicular symptoms following arthroplasty, who are found to have foraminal stenosis or a foraminal disc herniation, simple posterior foraminotomy can be the procedure of choice. In the cases where the radicular symptoms arise from a more centrally located lesion or in the cases of myelopathy from spinal canal stenosis, the options are removal of the device and thorough decompression followed by either an anterior fusion or reimplantation of the same arthroplasty device or a brand new one.

2. Current reports of procedures performed in failed CDR ([Table 6](#T6){ref-type="table"})
-------------------------------------------------------------------------------------------

In all reported surgical interventions following cervical arthroplasty, in which the implant needed replacement for reasons related to device malfunction, vertebral body osteolysis, infection, segmental kyphosis, lymphocytic reaction, or hyper-reactivity to metallosis, the surgeons chose to remove the implant and performed an arthrodesis \[[@B38][@B45][@B46][@B49][@B50][@B57][@B58]\]. In the cases of vertebral body or end-plate fracture during the initial surgery, removal of fragments and careful evaluation of the stability of the fracture followed by implantation of the artificial disc prosthesis was performed \[[@B47][@B48]\]. There were no reports of vertebral fracture during initial placement of the prosthesis, requiring corpectomy and/or fusion for stabilization. In a case of a fracture identified on postoperative imaging, evaluation of stability and close radiographic follow-up until the fracture healed was reported \[[@B24]\]. One reported case of prosthesis malposition required reoperation for proper repositioning of the device \[[@B33]\]. In the cases of persistent radiculopathy following cervical disc arthroplasty, posterior foraminotomy at the affected level was the procedure of choice \[[@B38][@B50]\]. For the cases of neurologic injury following CDR, implant removal was performed followed by corpectomy and thorough spinal cord decompression and fusion \[[@B59]\]. One report of persistent myelopathy following CDR was treated with posterior laminectomy for spinal cord decompression \[[@B26]\]. In a case of persistent neck and shoulder pain, implant removal and conversion to arthrodesis was performed \[[@B23]\].

3. Intraoperative approaches in CDR interventions
-------------------------------------------------

Removal of the arthroplasty device itself can present a multitude of challenges. There is no consensus in the literature on the techniques for removal of the artificial discs from the cervical spine. In the Synthes ProDisc-C Removal Technique Guide Manual \[[@B60]\], the recommendations are removal of the implant by disassembly of the components. The manufacturer recommends approaching the operative level through the original anterior incision followed by careful removal of scar tissue and osteophytes to expose the implant-bone junction. The implant removal should be done under distraction. Anterior cortices should be perforated using an awl, followed by removal of the polyethylene inlay using inlay separators. Forked or straight osteotomes should be used for the separation of the metal endplates from the vertebral bodies. All components are to be pulled out using a Kocher style forceps. In the Medtronic Bryan Surgical Technique manual, the manufacturer recommends using a chisel or osteotome to free the implant from the vertebral endplates after the disc space has been distracted \[[@B61]\]. There is no published guideline for removal of the Prestige cervical disc system.

Currently, there is a lack of literature on removal of previously implanted arthroplasty devices as well as on individual surgeon\'s experiences and techniques, used in complicated extractions of cervical artificial discs.

4. Potential future problems with CDR
-------------------------------------

There are several concerns associated with CDR that have not been addressed clinically due to the relative novelty of this technology. Implant survivorship in patients is one major concern. Subsequent development and management of adjacent level pathology is another. Do we implant more CDRs or convert to fusion? If we choose ACDF, what do we do with the device that is already implanted in the patient? Thirdly, the aging spine with deterioration of bone quality in the presence of these artificial devices could pose a challenge during extraction and subsequent stabilization procedures.

Motion preservation is the cornerstone of the cervical total disc replacement procedure. As such, the best candidates for motion preservation are young patients with good baseline segmental motion \[[@B12]\]. The bulk of the literature regarding artificial joint longevity comes from the orthopaedic literature of prosthetic hip and knee implants. The average age for the patients undergoing total knee and hip replacement is 68 and 67 years \[[@B62]\], respectively; while in one study assessing the sagittal cervical alignment following arthrodesis and arthroplasty surgery in 180 patients, the average age was 42.2 and 41.7, respectively \[[@B63]\]. A retrospective analysis of 11,606 primary total knee arthroplasties showed prosthesis survivorship of 91% at ten years, 84% at fifteen years, and 78% at twenty years following surgery \[[@B64]\]. Compared to the older and less active population with artificial knee and hip, the younger group with cervical disc replacement may experience greater prosthetic wear. If the numbers from the literature on artificial hip and knee can be translated into the cervical artificial disc longevity, the vast majority of patients who undergo CDR will need a surgical intervention at least once in their lifetime.

The only published study, investigating on the very late complications of CDR, evaluated complications occurring more than 4 years after the index surgical procedures in the FDA IDE trials of Bryan and Prestige discs \[[@B65]\]. Out of the 94 patients, 4.3% showed evidence of bone loss in peridevice vertebral body, 1.1% experienced posterior device migration, and 3.2% necessitated revision surgery. The authors concluded that similar to large-joint arthroplasty, delayed device-related complications may occur in CDR and that these complications commence well beyond the time frame for complications associated with more traditional cervical spine procedures.

Conclusions
===========

Reported rates of surgical interventions following failed CDR are low (mean, 2.4%; range, 0%-4.1%). The majority of these complications are related to poor patient selection and surgical techniques. However, a small percentage is also attributed to the device failure itself. With the growing number of patients receiving CDR, awareness needs to be established regarding the future need for surgical intervention as well as guidelines for approaches and techniques to minimize risks during reoperation, revision, and removal surgery.
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![A 56-year-old female presented with cervical radiculopathy. Radiographic studies showed C5/6 and C6/7 disc herniations with advanced spondylosis **(A, B)**. She underwent 2-level cervical disc replacement (CDR) with resolution of radiculopathy. Several months later, the patient developed severe axial neck pain. Radiographs demonstrated proper placement of CDRs **(C, D)** with lucency around the superior aspect of the C5/6 CDR **(E)**. The patient eventually underwent a one-level corpectomy **(F)**, with complete resolution of axial neck pain. This case demonstrates poor patient selection, as advanced spondylosis is a contraindication to CDR.](asj-9-471-g001){#F1}

###### Indications for cervical disc replacement
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MRI, magnetic resonance imaging; CT, computed tomography.

###### Contraindications to cervical disc replacement
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AIDS, autoimmune deficiency syndrome; HIV, human immunodeficiency virus.

###### Complications related to the cervical arthroplasty procedure
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###### Arthroplasty specific complications
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TDR, total disc replacement; ACDF, anterior cervical discectomy and fusion; PCM, porous-coated motion; FDA IDE, Food and Drug Administration investigational device exemption; ROM, range of motion.

###### Secondary intervention rates at the target level in cervical disc replacement
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MCT, multi-center trial; MCS, multi-center study; RCCT, randomized control clinical trial; FDA IDE, Food and Drug Administration investigational device exemption; PRCT, prospective randomized control trial.

###### Current reports of procedures performed for revision cervical disc replacement
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CDR, cervical disc replacement; PMCT, prospective multi-center trial; R: revision rate; PRCT, prospective randomized control trial PCT; ACDF, anterior cervical discectomy and fusion; RCS, randomized control study; PCT, prospective clinical trial.
